Financial Advocates Investment Management Co Diagnostics, Inc. Call Options Transaction History
Financial Advocates Investment Management
- $1.71 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA1.78MShares$906,8720.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$602,6320.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$283,3670.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$256,0320.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$176,2100.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $17.2M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...